Companies: 10,795·Total market cap: $144.5T
Belite Bio, Inc

Belite Bio, Inc

BLTENASDAQHealthcare● Active
$139.63
$-3.72(-2.60%)
Market Cap$5.6B
P/E Ratio—
52W High$200
52W Low$56.1
Overview

Belite Bio, Inc (BLTE) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001889109 · BLTE · NASDAQ · as of Jun 8, 2026

Filing snapshot

194
Total Filings
6-K
Latest Form
2026-05-20
Most Recent
2022
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001889109 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-31
Fiscal Year End
Mar 31, 2026
Accession No.
0001104659-26-037374
Primary Document
blte-20251231x20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001889109 · Accession 0001104659-26-037374

Latest Key Filings

10-QQuarterly Report

No recent filings

8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-20
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-21
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-31
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-03-31
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-02
View
Showing 1–15 of 127 filingsForm 4 / 144 hidden· 194 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001889109  |  Exchange: NASDAQ · Healthcare

Belite Bio, Inc (NASDAQ: BLTE) has submitted 194 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001889109, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Belite Bio, Inc's most comprehensive regulatory disclosure. The most recent Belite Bio, Inc 10-K was filed on 2026-03-31 for fiscal year ending 2026. Historical BLTE 10-K annual reports are available from 2021 through 2026.

Investors researching Belite Bio, Inc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
PRAX SEC Filings →LGND SEC Filings →MIRM SEC Filings →ACAD SEC Filings →CRNX SEC Filings →VKTX SEC Filings →DYN SEC Filings →SLNO SEC Filings →
→ BLTE Financials→ BLTE Earnings→ BLTE Insider Trades

Frequently Asked Questions

BLTE SEC Filings · 8 questions

Belite Bio, Inc (BLTE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 194 filings and access original documents at no cost. Belite Bio, Inc's CIK is 0001889109.

BLTE SEC filingsBelite Bio, Inc SEC documentsfind BLTE 10-K